Post GLOBVAC – alternate funding opportunities

Karine Kålsås from the Research Council of Norway (RCN) gave a brief presentation at the Global Health Norway Conference in Oslo, 10 April. 

Kålsås is one of the RCN Advisors responsible for administering the RCN Global Health and Vaccination Research (GLOBVAC)programme. Begun in 2006, the programme was renewed for a second period that will end in 2020. A total of 58 project applications were received for the recent (February) GLOBVAC funding call. The next and final GLOBVAC conference will take place in 2020. Read more on the programme web pages. 

Kålsås outlined a number of future funding possibilities for Norwegian global health researchers. 

European & Developing Countries Clinical Trials Partnership (EDCTP)

  • All Nordic lands are involved with this partnership
  • Numerous funding opportunities
  • Autumn 2018 – workshop with EDCTP in Norway (details to be announced) 

European & Developing Countries Clinical Trials Partnership (CEPI)

Kålsås urged global health researchers to consider planning to apply for a European Research Council (ERC) grant – advanced or starting researcher.

Rcn Way Forward Ppt